Mark Hasleton

Mark Hasleton

Amministratore Delegato presso
ProTA Therapeutics Pty Ltd.
54 anni
Health Technology
Consumer Services

Profilo

Mark Hasleton currently works at Prota Therapeutics Pty Ltd., as Chief Executive Officer.
Dr. Hasleton also formerly worked at Teva Pharmaceutical Industries Ltd., as Senior Director-Global New Therapeutic Entities from 2010 to 2018, Bristol Myers Squibb Co., as Manager-EMEA Business Operations, and Oramed Pharmaceuticals, Inc., as Vice President-Business Development from 2018 to 2019.
Dr. Hasleton received his doctorate degree from Imperial College London, graduate degree from The University of Manchester, and Masters Business Admin degree from Imperial College Business School.

Posizioni attive di Mark Hasleton

SocietàPosizioneInizio
Amministratore Delegato -

Precedenti posizioni note di Mark Hasleton

SocietàPosizioneFine
ORAMED PHARMACEUTICALS INC. Corporate Officer/Principal 27/08/2019
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01/01/2018
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Mark Hasleton

Formazione di Mark Hasleton

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

77

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Mercati
  2. Insiders
  3. Mark Hasleton